{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:32:46Z","timestamp":1780579966038,"version":"3.54.1"},"reference-count":24,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/09546634.2019.1708242","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T12:08:10Z","timestamp":1576930090000},"page":"783-787","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration"],"prefix":"10.1080","volume":"32","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"SUNY Stonybrook Medical School, Stonybrook, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.062"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.1260"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1571039"},{"key":"CIT0004","unstructured":"\u00a0Federal Drug Administration. 2019. Federal Drug Administration Adverse Event Reporting System [database]. Available from: https:\/\/fis.fda.gov\/sense\/app\/d10be6bb-494e-4cd2-82e4-0135608ddc13\/sheet\/33a0f68e-845c-48e2-bc81-8141c6aaf772\/state\/analysis"},{"key":"CIT0005","unstructured":"\u00a0Google. 2019. Google Trend [database]. Available from: https:\/\/trends.google.com\/trends\/?geo=US"},{"key":"CIT0006","unstructured":"\u00a0LAMISIL (terbinafine hydrochloride) tablets [package insert]. East Hanover (NJ): Novartis Pharmaceuticals Corporation; [accessed 2019 Sep 25]. Available from: https:\/\/www.pharma.us.novartis.com\/sites\/www.pharma.us.novartis.com\/files\/Lamisil_tablets.pdf"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6895.26-b"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02485.x"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000181462.08683.0C"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.04105.x"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","volume":"73","author":"Faergemann J","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/18.4.419"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1998.1998015464.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13561"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.4483"},{"key":"CIT0016","unstructured":"\u00a0Walmart, Inc. Retail prescription program drug list; 2019 [accessed 2019 Oct 2]. Available from: https:\/\/www.goodrx.com\/spironolactone?label_override=spironolactone&form=tablet&dosage=100mg&quantity=30"},{"key":"CIT0017","unstructured":"\u00a0Centers for Medicare & Medicaid Services. Clinical laboratory fee schedule. 2019 [accessed 2019 Oct 2]. Available from: https:\/\/www.cms.gov\/apps\/ama\/license.asp?file=\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/Downloads\/19CLABQ1.zip"},{"key":"CIT0018","unstructured":"\u00a0Centers for Medicare & Medicaid Services. Medicare provider utilization and payment data. 2017 [accessed 2019 Oct 2]. Available from: https:\/\/data.cms.gov\/Medicare-Physician-Supplier\/Medicare-Provider-Utilization-and-Payment-Data-Phy\/fs4p-t5eq\/data"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3578"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80273-X"},{"key":"CIT0021","unstructured":"\u00a0Food and Drug Administration. Aldactone SPORANOX\u00ae (itraconazole) Capsules. Physician Labeling. [accessed 2019 Oct 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020083s040s041s044lbl.pdf"},{"key":"CIT0022","unstructured":"\u00a0Food and Drug Administration. DIFLUCAN\u00ae (fluconazole) Tablets. Physician Labeling. [accessed 2019 Oct 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019949s051lbl.pdf"},{"key":"CIT0023","unstructured":"\u00a0Food and Drug Administration. Jublia (efinaconazole) approval date. [accessed 2019 Oct 2]. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshot-jublia-efinaconazole"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2019.1708242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:54:47Z","timestamp":1695545687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2019.1708242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/09546634.2019.1708242"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2019.1708242","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}